In the present study, we aimed to evaluate the serum levels of these biomarkers (fet-A, DKK-1, Gal-3, IL-32, and CST) in RA patients and to assess their associations with RA parameters and with surrogate markers of CVD. This evidence concerns the gene IL32 and rheumatoid arthritis.